SARVARIYELLAPRAGADASARVARI YELLAPRAGADA0.000000000000000.00000000000000998YELLAPRAGADA, SARVARIProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 16047615Authorship 1617533Authorship 162199525572917Girnius SK, Lee S, Kambhampati S, Rose MG, Mohiuddin A, Houranieh A, Zimelman A, Grady T, Mehta P, Behler C, Hayes TG, Efebera YA, Prabhala RH, Han A, Yellapragada SV, Klein CE, Roodman GD, Lichtenstein A, Munshi NCBritish journal of haematologyA Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43.Br J Haematol2015-01-08T00:00:002015A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation.25709889Nautiyal K, Li R, Yellapragada S, Thiagarajan P, Mims M, Rivero GLeukemia research reportsProgressive transfusion and growth factor independence with adjuvant sertraline in low risk myelodysplastic syndrome treated with an erythropoiesis stimulating agent and granulocyte-colony stimulating factor. Leuk Res Rep. 2015; 4(1):1-3.Leuk Res Rep2014-12-16T00:00:002014Progressive transfusion and growth factor independence with adjuvant sertraline in low risk myelodysplastic syndrome treated with an erythropoiesis stimulating agent and granulocyte-colony stimulating factor.25793032Khalid U, Awar O, Verstovsek G, Cheong B, Yellapragada SV, Jneid H, Deswal A, Virani SSMethodist DeBakey cardiovascular journalCase report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):53-8.Methodist Debakey Cardiovasc J2015-01-01T00:00:002015Case report: isolated cardiac amyloidosis: an enigma unravelled.LeukemiaLymphoma-MyelomaStem Cell TransplantationMD AndersonHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorDONNA MWEBERDONNA M WEBER8507WEBER, DONNA MProfessorMUZAFFAR HQAZILBASHMUZAFFAR H QAZILBASH9055QAZILBASH, MUZAFFAR HProfessorROBERTORLOWSKIROBERT ORLOWSKI9449ORLOWSKI, ROBERTProfessorAuthorship 818254BIJANNAJAFIBIJAN NAJAFI11055NAJAFI, BIJANProfessorAuthorship 302718226798526Molina M, Yellapragada S, Mims M, Rahman E, Rivero GCase reports in hematologyPulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia. Case Rep Hematol. 2015; 2015:357461.Case Rep Hematol2015-12-20T00:00:002015Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia.74Professor10Assistant Professor54Instructor14Associate Professor3Adjunct Associate Professor78Professor EmeritusQUILLANHUANGQUILLAN HUANG11507HUANG, QUILLANAssistant ProfessorAuthorship 323365227153790Amini B, Yellapragada S, Shah S, Rohren E, Vikram RRadiologic clinics of North AmericaState-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias. Radiol Clin North Am. 2016 May; 54(3):581-96.Radiol Clin North Am2016-03-21T00:00:002016State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias.21417907Alva AS, Hahn NM, Aparicio AM, Singal R, Yellapragada S, Sonpavde GFuture oncology (London, England)Hypomethylating agents for urologic cancers. Future Oncol. 2011 Mar; 7(3):447-63.Future Oncol2011-03-01T00:00:002011Hypomethylating agents for urologic cancers.22191037Albany C, Alva AS, Aparicio AM, Singal R, Yellapragada S, Sonpavde G, Hahn NMProstate cancerEpigenetics in prostate cancer. Prostate Cancer. 2011; 2011:580318.Prostate Cancer2011-11-30T00:00:002011Epigenetics in prostate cancer.17768123Guchhait P, Dasgupta SK, Le A, Yellapragada S, L?pez JA, Thiagarajan PHaematologicaLactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood. Haematologica. 2007 Sep; 92(9):1266-7.Haematologica2007-09-01T00:00:002007Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood.One Baylor PlazaHouston, 77030TX28133556Chang E, Rivero G, Jiang B, Yellapragada S, Thiagarajan PCase reports in hematologyGelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review. Case Rep Hematol. 2017; 2017:1950724.Case Rep Hematol2017-01-04T00:00:002017Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review.Authorship 7021314Authorship 784646227061100Li A, Yellapragada SV, Mims M, Frolov A, Rivero GABritish journal of haematologySignificant improvement in overall survival among patients diagnosed with low-risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors. Br J Haematol. 2017 04; 177(1):142-144.Br J Haematol2016-04-07T00:00:002016Significant improvement in overall survival among patients diagnosed with low-risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors.Authorship 881851829342442Chang E, Rivero G, Patel NR, Chiao EY, Lai S, Bajaj K, Mbue JE, Yellapragada SVClinical lymphoma, myeloma & leukemiaHIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab. Clin Lymphoma Myeloma Leuk. 2018 02; 18(2):e143-e146.Clin Lymphoma Myeloma Leuk2018-01-03T00:00:002018HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab.true1ProfessorProfessorD009101Disorders36221390.432145Multiple MyelomaD014728Living Beings29616550.437185VeteransD014808Disorders901160.8868Vitamin D DeficiencyAuthorship 916825930020193Chang E, Sabichi AL, Kramer JR, Hartman C, Royse KE, White DL, Patel NR, Richardson P, Yellapragada SV, Garcia JM, Chiao EYJournal of immunotherapy (Hagerstown, Md. : 1997)Nivolumab Treatment for Cancers in the HIV-infected Population. J Immunother. 2018 Oct; 41(8):379-383.J Immunother2018-10-01T00:00:002018Nivolumab Treatment for Cancers in the HIV-infected Population.Department of MedicineDepartment of Pathology & ImmunologyDepartment of SurgerySurgery-Vascular Surgery DivMedicine-General Med/VAMCMedicine-General MedicineMedicine-Hematology & OncologyPathologyBaylor College of MedicineHAOLIUHAO LIU0.000000000000000.000000000000001139LIU, HAOAdjunct Associate ProfessorWEEI-CHINLINWEEI-CHIN LIN0.000000000000000.000000000000001687LIN, WEEI-CHINProfessorJULIENANGIAJULIE NANGIA0.000000000000000.000000000000001756NANGIA, JULIEAssociate ProfessorGORDANAVERSTOVSEKGORDANA VERSTOVSEK0.000000000000000.000000000000002100VERSTOVSEK, GORDANAAssociate ProfessorYVONNESADAYVONNE SADA0.000000000000000.000000000000003850SADA, YVONNEAssociate ProfessorGERALDCYPRUSGERALD CYPRUS0.000000000000000.000000000000002733CYPRUS, GERALDProfessor Emeritus1.2120.0033548499research areas1.748570.019823132coauthor of35.91923.2582660similar to1130selected publicationsAuthorship 944031630665876Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV, Sada YH, Schwenk M, Najafi BJournal of geriatric oncologyUsing wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatr Oncol. 2019 11; 10(6):960-967.J Geriatr Oncol2019-01-18T00:00:002019Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN.Authorship 945322231003998Fillmore NR, Yellapragada SV, Ifeorah C, Mehta A, Cirstea D, White PS, Rivero G, Zimolzak A, Pyarajan S, Do N, Brophy M, Munshi NCBloodWith equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019 06 13; 133(24):2615-2618.Blood2019-04-19T00:00:002019With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.D000073496671100.832921FrailtyD000076251461050.853781Wearable Electronic Devicestrue1Assistant ProfessorAssistant Professortrue1InstructorInstructortrue1Associate ProfessorAssociate ProfessorAuthorship 987787132315398Yellapragada SV, Fillmore NR, Frolov A, Zhou Y, Dev P, Yameen H, Ifeorah C, Do NV, Brophy MT, Munshi NCBlood advancesVitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma. Blood Adv. 2020 04 28; 4(8):1643-1646.Blood Adv2020-04-28T00:00:002020Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma.Authorship 1007807833363894Nguyen CB, Li M, Verstovsek G, Sen U, Swierenga C, Huang Q, Rivero G, Yellapragada SVClinical case reportsPrimary bone lymphoma of the ilium successfully treated without radiation. Clin Case Rep. 2020 Dec; 8(12):3130-3133.Clin Case Rep2020-09-23T00:00:002020Primary bone lymphoma of the ilium successfully treated without radiation.Authorship 1010387833523236Fillmore NR, DuMontier C, Yildirim C, La J, Epstein MM, Cheng D, Cirstea D, Yellapragada S, Abel GA, Gaziano JM, Do N, Brophy M, Kim DH, Munshi NC, Driver JAJournal of the National Cancer InstituteDefining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma. J Natl Cancer Inst. 2021 08 02; 113(8):1084-1093.J Natl Cancer Inst2021-08-02T00:00:002021Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.Authorship 1012850833671345Maneix L, Sweeney MA, Lee S, Iakova P, Moree SE, Sahin E, Lulla P, Yellapragada SV, Tsai FTF, Catic ACancersThe Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers (Basel). 2021 Feb 17; 13(4).Cancers (Basel)2021-02-17T00:00:002021The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma.Authorship 1020526634091147Kang GE, Murphy TK, Kunik ME, Badr HJ, Workeneh BT, Yellapragada SV, Sada YH, Najafi BGait & postureThe detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy. Gait Posture. 2021 07; 88:161-166.Gait Posture2021-05-27T00:00:002021The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy.true1Associate ProfessorAssociate ProfessorAuthorship 1024318934207459DuMontier C, Fillmore NR, Yildirim C, Cheng D, La J, Orkaby AR, Charest B, Cirstea D, Yellapragada S, Gaziano JM, Do N, Brophy MT, Kim DH, Munshi NC, Driver JACancersContemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System. Cancers (Basel). 2021 Jun 18; 13(12).Cancers (Basel)2021-06-18T00:00:002021Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System.Authorship 1027563234383000Al Hadidi S, Yellapragada SJAMA oncologyTreatment Options for Relapsed and Refractory Multiple Myeloma: A Luxury or a Challenge? JAMA Oncol. 2021 10 01; 7(10):1449-1450.JAMA Oncol2021-10-01T00:00:002021Treatment Options for Relapsed and Refractory Multiple Myeloma: A Luxury or a Challenge?Authorship 1028274534428278Fillmore NR, Cirstea D, Munjuluri A, Yameen H, Yellapragada SV, Do NV, Brophy MT, Szalat RE, Munshi NCBlood advancesLack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study. Blood Adv. 2021 09 28; 5(18):3511-3514.Blood Adv2021-09-28T00:00:002021Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study.Authorship 1035871634938552Khan S, Premji S, Huang Q, Verstovsek G, Bushan S, Yellapragada SVClinical case reportsAn eye-catching atypical illustration of the evaluation and management of AL amyloidosis secondary to myeloma. Clin Case Rep. 2021 Dec; 9(12):e05176.Clin Case Rep2021-12-09T00:00:002021An eye-catching atypical illustration of the evaluation and management of AL amyloidosis secondary to myeloma.Authorship 10547427Authorship 1059990435997953Khan S, Alam ST, Ramos RT, Mbue JE, Apostolidou E, Rivero GA, Yellapragada SVClinical hematology internationalLuspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series. Clin Hematol Int. 2022 Aug 23.Clin Hematol Int2022-08-23T00:00:002022Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series.35924430Alam ST, Dongarwar D, Lopez E, Yellapragada S, Rivero G, Huang Q, Miler-Chism C, Mims M, Salihu HMCancer medicineDisparities in mortality among acute myeloid leukemia-related hospitalizations. Cancer Med. 2023 02; 12(3):3387-3394.Cancer Med2022-08-04T00:00:002022Disparities in mortality among acute myeloid leukemia-related hospitalizations.Authorship 10646741036846090Maneix L, Iakova P, Moree SE, Hsu JI, Mistry RM, Stossi F, Lulla P, Sun Z, Sahin E, Yellapragada SV, Catic ACancer research communicationsProteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation. Cancer Res Commun. 2022 12; 2(12):1693-1710.Cancer Res Commun2022-12-27T00:00:002022Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.true1Professor EmeritusProfessor Emeritustrue1Adjunct Associate ProfessorAdjunct Associate ProfessorAuthorship 1074327437389421Friedman DR, Rodgers TD, Kovalick C, Yellapragada S, Szumita L, Weiss ESThe Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care AssociationVeterans with blood cancers: Clinical trial navigation and the challenge of rurality. J Rural Health. 2024 Jan; 40(1):114-120.J Rural Health2023-06-30T00:00:002023Veterans with blood cancers: Clinical trial navigation and the challenge of rurality.true1ProfessorProfessortrue1Assistant ProfessorAssistant ProfessorSHAMISKHANSHAMIS KHAN19103KHAN, SHAMISAssistant Professortrue1Associate ProfessorAssociate ProfessorAuthorship 10795168Authorship 1077893237731771Hussain M, Yellapragada S, Al Hadidi SBlood and lymphatic cancer : targets and therapyDifferential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article. Blood Lymphat Cancer. 2023; 13:33-57.Blood Lymphat Cancer2023-09-15T00:00:002023Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article.37582048DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, Hassan H, Yellapragada S, Abel GA, Gaziano JM, Do NV, Brophy M, Kim DH, Munshi NC, Fillmore NR, Driver JABlood advancesMore intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected]. Blood Adv. 2023 10 24; 7(20):6275-6284.Blood Adv2023-10-24T00:00:002023More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].true1ProfessorProfessorAuthorship 1088170838297103Cay G, Sada YH, Dehghan Rouzi M, Uddin Atique MM, Rodriguez N, Azarian M, Finco MG, Yellapragada S, Najafi BScientific reportsHarnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer. Sci Rep. 2024 01 31; 14(1):2612.Sci Rep2024-01-31T00:00:002024Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorJOHNMBUEJOHN MBUE7232MBUE, JOHNInstructorAuthorship 307765Authorship 791895